In a much awaited event, CM Siddaramaiah presented the State Budget 2024-25 in front of the Karnataka Assembly. The budget focuses on welfare and inclusive development, with a priority towards supporting farmers, women, youth and marginalized sections of the society. Ensuring fiscal discipline, the budget is estimated to have total revenue receipts of Rs.2,63,178 crore, keeping the fiscal deficit within 3% and outstanding liabilities within 25% of GSDP.
Investors eagerly await Eli Lilly's Q4 2023 results and 2024 guidance as the company's blockbuster weight-loss drug Zepbound receives FDA approval and surpasses sales expectations. Zepbound's first-of-its-kind dual action sets it apart from existing therapies and has caused fierce competition in the anti-obesity market, with GlobalData predicting it to reach $4.1 billion in US sales by 2031. However, concerns about supply constraints loom as Lilly prices Zepbound at a 21% discount compared to the reigning therapy, Novo Nordisk's Wegovy.